Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The anti-tumor activity of cetuximab prior to chemoradiotherapy and the safety and
tolerability of cetuximab with concurrent chemoradiation will be determined in women with
locally advanced or metastatic cervical carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
University of Virginia
Collaborators:
Bristol-Myers Squibb Eli Lilly and Company ImClone LLC Washington University School of Medicine